PHOENIX, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (CELZ), (the “Company”), a clinical-stage biotechnology company pioneering regenerative immunotherapy, today ...

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) announced that its stockholders approved a proposal to allow the full exercise of warrants to purchase 2,790,340 shares of common stock. The ...